Abstract
Background Cardiovascular implantable electronic devices (CIEDs) such as permanent pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy devices alleviate morbidity and mortality in various diseases. There is a paucity of real-world data on CIED complications and trends.
Objectives Describe trends in noninfectious CIED complications over the past three decades in Olmsted County.
Methods The Rochester Epidemiology Project is a medical records linkage system comprising records of over 500,000 residents of Olmsted County from 1966-current. CIED implants between 1988-2018 were determined. Trends in noninfectious complications within 30 days of implant were analyzed.
Results 175 out of 2536 (6.9%) patients who received CIED experienced device complications. 3.8% of the implants had major complications requiring intervention. Lead dislodgement was the most common (2.9%), followed by hematoma (2.1%). Complications went up from 1988 to 2005, then showed a downtrend until 2018, driven by a decline in hematomas in the last decade (p<0.01). Those with complications were more likely to have prosthetic valves. Obesity appeared to have a protective effect in a multivariate regression model. The mean Charlson comorbidity score has trended up over the 30 years.
Conclusions Our study describes a real-world trend of CIED complications over three decades. Lead dislodgements and hematomas were the most common complications. Complications have declined over the last decade due to safer practices and a better understanding of anticoagulant management.
Competing Interest Statement
Paul A. Friedman is the global principal investigator on the Medtronic extravascular ICD study, and has served as an advisor, with all funds going to Mayo Clinic. Siva K. Mulpuru is on the Biotronik SICD advisory board, NIH CICS study section, received funding from Mayo Clinic Prospective study grant, and a Biosense Webster educational conference participant. Yong-Mei Cha received research funding from Medtronic Inc. The other authors have no relevant disclosures.
Funding Statement
This study was made possible using the resources of the Rochester Epidemiology Project, which is supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG034676. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study is supported by the Mayo Clinic, Department of Cardiovascular Medicine, and Medtronic Inc. research funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Our study was approved by the Mayo Clinic Institutional Review Board and received proper ethical oversight.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
We will be happy to share any data or analysis as requested
Abbreviations:
- CIED
- Cardiac Implantable Electronic Devices
- ICD
- Implantable Cardioverter-Defibrillator
- PPM
- Permanent Pacemaker
- CRT
- Cardiac Resynchronization Therapy
- CRT-P
- Cardiac Resynchronization Therapy – Pacemaker
- CRT-D
- Cardiac Resynchronization Therapy – Defibrillator
- FDA
- Food and Drug Administration
- REP
- Rochester Epidemiology Project
- ICD-9/10
- International Classification of Diseases 9th /10th Revision
- CPT
- Current Procedural Terminology
- NIS
- National Inpatient Sample
- NCDR
- National Cardiovascular Data Registry
